Newsroom
September 27, 2024
Virginia Kaklamani, MD, clinical professor, Department of Medicine, Division of Hematology and Oncology, and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was quoted in this article. Read More
September 19, 2024
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was recently awarded a $12.6 million program project grant (P01) from the National Institutes of Health’s National Cancer Institute to expand collaborative efforts to explore the biological mechanisms of BRCA1, BRCA2 and related tumor suppressors and to shed light on potential […]
August 9, 2024
This news segment mentions that scientists from The University of Texas Health Science Center at San Antonio led a pilot study showing that the antiretroviral drug lamivudine shows potential for Alzheimer’s disease treatment. Watch Now
August 9, 2024
Andrew Brenner, MD, PhD, professor and chair of neuro-oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
August 9, 2024
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More
August 9, 2024
Andrew Brenner, MD, PhD, professor and chair of Neuro-Oncology research at the Mays Cancer Center at The University of Texas Health Science Center at San Antonio, and William Kelly, MD, assistant professor, Department of Medicine, Division of Hematology and Oncology, were quoted in this article. Read More